RPS Joins DATATRAK's Connect Partner Program™

Global CRO Standardizes on DATATRAK ONE™ as their Clinical Enterprise Solution

Apr 02, 2012, 07:30 ET from DATATRAK International, Inc.

CLEVELAND, April 2, 2012 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced RPS (ReSearch Pharmaceutical Services, Inc.) selected DATATRAK as a preferred vendor and joined DATATRAK's CRO Connect Partner™ program. RPS is a global Contract Research Organization (CRO) with more than 3,000 employees operating in 45 countries.

"RPS is excited to announce that it has selected DATATRAK as one of its preferred vendors in order to maximize the benefit and minimize the cost in using DATATRAK's unified software suite, DATATRAK ONE™," stated Daniel Perlman, RPS CEO and Chairman. "We strongly believe that the industry leading solutions of RPS, combined with DATATRAK's robust Technology solution will bring our customers excellent quality, data integrity and responsiveness at a highly competitive price. After several years of experience working together, this seemed to be the next logical step in enhancing our combined offering."

"RPS is a great new addition to our CRO Connect Partner™ program, and we are excited to be providing them the most powerful SaaS clinical research platform in the world," stated Laurence P. Birch, DATATRAK's Chairman of the Board and CEO. "This partnership was a natural progression as a result of our work with RPS on client studies and their participation in our Product Advisory Council.  We look forward to continued growth for both companies."

About RPS

RPS provides comprehensive global Phase I-IV clinical development solutions to the Pharmaceutical, Biotechnology, Medical Device and Diagnostic industries. By combining our highly experienced clinical research operations infrastructure with the industry's largest resourcing engines, RPS is uniquely positioned to offer our Customers a broad spectrum of outsourcing solutions. These solutions range from globally embedded functional and cross-functional programs to enhanced global full-service solutions, and are powered by highly experienced project teams providing innovative, seamless, cost-effective and high quality services. With more than 4,000 employees, RPS operates in 64 countries across the globe. See http://www.rpsweb.com for more information. 


DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and devices studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 16, 2012 announcing its fourth quarter and full year results for 2011. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

SOURCE DATATRAK International, Inc.